Whether you’re exploring novel chemical space around identified psychedelic pharmacophores or scaling lead compounds toward in vivo studies and pre-GMP process development, Cayman’s Medicinal Chemistry & Structural Biology services can offer a fully integrated, multidisciplinary approach to developing a wide range of therapeutics.

Cayman’s dedicated team of medicinal and organic chemists is available to you on a contract basis to help accelerate your preclinical program. Our multidisciplinary team includes more than 100 years of combined pharma experience, specialists in the derivatization and conjugation of hallucinogenic and psychotropic compounds, and a skilled team of structural biologists and biochemists. Access to state-of-the-art resources such as Schrödinger suite software and synchrotron beamlines at the Argonne National Laboratory, are available to drive both ligand- and structure-based drug design, lead optimization, and process scaling from milligram to kilogram quantities.